Vincerx Pharma has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Vincerx Pharma has averaged an EPS surprise of 0.59% and a revenue surprise of 0.00%.
Analyze the earnings history of Vincerx Pharma using advanced sorting and filters.
The chart below shows Vincerx Pharma's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-3.40 | $-4.40 | 22.7 % |
| Q2 | 2024-08-08 | $-1.00 | $-4.00 | 75.0 % |
| Q1 | 2024-05-14 | $-11.60 | $-5.80 | -100.0 % |
| Q4 | 2024-03-29 | $-4.60 | $-7.40 | 37.8 % |
The chart below shows Vincerx Pharma's reported revenue compared to analyst estimates over recent quarters.
Vincerx Pharma (VINC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 15, 2025 for Q1.
Vincerx Pharma (VINC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 15, 2025 for Q1 and the Actual EPS was $-1.40, which missed the estimate of $0.00.
Vincerx Pharma (VINC) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 15, 2025 for Q1 and the Actual Revenue was $0.00, which hit the estimate of $0.00.